172 related articles for article (PubMed ID: 20973954)
1. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
De Nardo CM; Lenzo JC; Pobjoy J; Hamilton JA; Cook AD
Arthritis Res Ther; 2010; 12(5):R199. PubMed ID: 20973954
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.
Cook AD; De Nardo CM; Braine EL; Turner AL; Vlahos R; Way KJ; Beckman SK; Lenzo JC; Hamilton JA
Arthritis Res Ther; 2010; 12(2):R37. PubMed ID: 20196869
[TBL] [Abstract][Full Text] [Related]
3. Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.
Cook AD; Braine EL; Campbell IK; Hamilton JA
Am J Pathol; 2002 Mar; 160(3):917-26. PubMed ID: 11891190
[TBL] [Abstract][Full Text] [Related]
4. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models.
Li J; Guo Y; Holmdahl R; Ny T
Arthritis Rheum; 2005 Aug; 52(8):2541-8. PubMed ID: 16052596
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
[TBL] [Abstract][Full Text] [Related]
7. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
[TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator deficiency exacerbates arthritis.
Yang YH; Carmeliet P; Hamilton JA
J Immunol; 2001 Jul; 167(2):1047-52. PubMed ID: 11441114
[TBL] [Abstract][Full Text] [Related]
9. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
[TBL] [Abstract][Full Text] [Related]
10. The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.
Li J; Ny A; Leonardsson G; Nandakumar KS; Holmdahl R; Ny T
Am J Pathol; 2005 Mar; 166(3):783-92. PubMed ID: 15743790
[TBL] [Abstract][Full Text] [Related]
11. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
12. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.
García S; Forteza J; López-Otin C; Gómez-Reino JJ; González A; Conde C
Arthritis Res Ther; 2010; 12(6):R224. PubMed ID: 21190566
[TBL] [Abstract][Full Text] [Related]
14. Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production.
Pinto LG; Talbot J; Peres RS; Franca RF; Ferreira SH; Ryffel B; Aves-Filho JC; Figueiredo F; Cunha TM; Cunha FQ
Arthritis Res Ther; 2015 Sep; 17(1):235. PubMed ID: 26330334
[TBL] [Abstract][Full Text] [Related]
15. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
[TBL] [Abstract][Full Text] [Related]
17. The roles of urokinase-type plasminogen activator in leukocyte infiltration and inflammatory responses in mice corneas treated with lipopolysaccharide.
Sugioka K; Kodama A; Yoshida K; Okada K; Mishima H; Aomatsu K; Matsuo O; Shimomura Y
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5338-50. PubMed ID: 25061113
[TBL] [Abstract][Full Text] [Related]
18. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis.
Van Ness K; Chobaz-Péclat V; Castellucci M; So A; Busso N
Rheumatology (Oxford); 2002 Feb; 41(2):136-41. PubMed ID: 11886960
[TBL] [Abstract][Full Text] [Related]
20. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
Ronday HK; Smits HH; Quax PH; van der Pluijm G; Löwik CW; Breedveld FC; Verheijen JH
Br J Rheumatol; 1997 Jan; 36(1):9-15. PubMed ID: 9117184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
